Medicina-buenos Aires最新文献_第6页

[Pre-employment medical exams: A Greek tragedy]. [入职前体检：希腊悲剧]。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Eduardo L De Vito

引用次数: 0

[Treatment of severe tricuspid insufficiency associated with right ventricular dysfunction through the implantation of a transcatheter bi-caval system]. [经导管双腔静脉系统植入治疗伴右室功能不全的严重三尖瓣功能不全]。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Carolina Gálvez Gil, Jorge Szarfer, Federico Albornoz, Federico Blanco, Pablo Rivara, Gerardo Gigena

引用次数: 0

Pseudo-Wellens pattern A, triggered by takotsubo syndrome. 伪韦伦斯A型，由takotsubo综合征引发。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Edwin A Rodríguez, Cristina Espinosa De La Ossa, Álvaro F Vargas Pelaez, Sandra P Swieszkowski

引用次数: 0

[Dose banding. Observational study on cost optimization in chemotherapy]. (剂量条带。化疗成本优化的观察性研究[j]。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

José M Sanguinetti, Federico N Cisneros, Gustavo H Marin

{"title":"[Dose banding. Observational study on cost optimization in chemotherapy].","authors":"José M Sanguinetti, Federico N Cisneros, Gustavo H Marin","doi":"","DOIUrl":"","url":null,"abstract":"Introduction: The cost of cancer treatments is a concern of the health system. The search for strategies that optimize the costs of these treatments is essential to ensure access to them. Dose banding is a methodology that has been successfully implemented in several countries, demonstrating effectiveness and efficiency. It is based on establishing dose bands rounding cytostatics ±5% and monoclonal antibodies ±10%, optimizing commercial presentations and avoiding waste. In our country there are no experiences with this system. The objective was to evaluate the savings in drug costs using dose banding.Material and methods: Observational study of the costs of oncology drugs in a sample of patients affiliated with the Institute of Social Work of the Armed Forces (IOSFA) diagnosed with breast, colon and prostate cancer who received treatment during June 2022. The cost of each dose was determined and was simulated according to the dose banding system.Results: Twenty-eight patients who received 29 doses were analysed.Diagnoses: colon cancer (n:7; 25.0%), breast cancer (n:18; 64.3%) and prostate cancer (n:3; 10.7%). Mean age 61.7 years (range 34-85 years); 22 patients were female. Drugs tested: bevacizumab, cabazitaxel, cetuximab, docetaxel, trastuzumab, and trastuzumab+emtasine. The total cost was $14 101 596.39 (U$S 112 605.58 -sale value of the U.S. dollar in the Banco Nación Argentina, June 30, 2022), the simulation of the application of dose banding showed a cost of $11 185 371.49 (U$S 89 318.63). The potential savings are 20.7%.Discussion: Dose standardization may represent a strategy that generates a significant decrease in cancer treatment costs.","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 1","pages":"96-100"},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Update on the treatment of hereditary angioedema in Argentina]. 【阿根廷遗传性血管性水肿治疗的最新进展】。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Blas Larrauri, Alejandro Malbrán, Eloisa Malbrán

引用次数: 0

Diffusion restriction in the fornix following endovascular treatment of an anterior communicating artery aneurysm. 前交通动脉瘤血管内治疗后的穹窿扩散受限。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Santiago A Cutiller, Juan J Cirio, Edwina L L Rodríguez, Jose R Beltran, Vanesa V Goytia, Pedro Lylyk

引用次数: 0

[Are dreams merely dreams?] 梦仅仅是梦吗？］

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Basilio A Kotsias

引用次数: 0

[Bibliometric analysis: second victim experience and impact of adverse events]. [文献计量学分析：第二次受害者经历和不良事件的影响]。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Luz K González Julio, Kisi Padilla Constante, Lugo M Barbosa Guerrero

{"title":"[Bibliometric analysis: second victim experience and impact of adverse events].","authors":"Luz K González Julio, Kisi Padilla Constante, Lugo M Barbosa Guerrero","doi":"","DOIUrl":"","url":null,"abstract":"Introduction: Adverse events in healthcare can have significant emotional and psychological consequences for the professionals involved, known as \"second victims.\" These effects include guilt, anxiety, and depression, which can affect their performance and well-being. This highlights the need for effective interventions to mitigate the effects of these events on professionals.Materials and methods: A bibliometric analysis was conducted on the second victim experience to evaluate the use and validity of the SVEST (Second Victim Experience and Support Tool) in recent studies. Key publications were reviewed to analyze the application of SVEST and the effectiveness of support strategies implemented in healthcare organizations.Results: The analysis confirmed that SVEST is a reliable tool for measuring the emotional impact on second victims and for assessing the quality of the support they receive. Studies highlighted the effectiveness of peer support programs and leadership training as key strategies to mitigate the negative consequences of adverse events.Discussion: The findings underscore the importance of establishing structured support systems within healthcare organizations to create a more supportive and resilient environment. Support and training initiatives significantly contribute to the well-being and performance of affected healthcare professionals, enhancing their ability to cope with the emotional effects of adverse events and strengthening their professional practice.","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 3","pages":"511-517"},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144512125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hepatic adenomatosis. 肝adenomatosis。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Pedro Henrique Segatt, André Dias Almeida Mucci De Aguiar, Bruno Fernandes Barros Brehme De Abreu, Gregory De Oliveira Perdizes, Márcio Luís Duarte

引用次数: 0

[A rare case of autoimmune polyglandular syndrome type 2 in an elderly patient]. [1例罕见的老年自身免疫性多腺综合征2型]。

IF 0.6 4区医学

Medicina-buenos Aires Pub Date : 2025-01-01

Abrar-Ahmad Zulfiqar

{"title":"[A rare case of autoimmune polyglandular syndrome type 2 in an elderly patient].","authors":"Abrar-Ahmad Zulfiqar","doi":"","DOIUrl":"","url":null,"abstract":"Autoimmune polyglandular syndrome type 2 (APS-2) is a rare and complex clinical entity, whose etiology and evolution are not fully understood. We present the case of a 78-year-old male, followed and treated for Addison's disease for 45 years, in whom macrocytosis with a hemoglobin level of 11.8 g/dL was detected during a routine evaluation. The immunological vitamin B12 deficiency led to the diagnosis of Biermer's disease, while the thyroid, diabetic and liver immunological evaluations were negative. Treatment was started with periodic injections of vitamin B12 and hormone replacement therapy (glucocorticoids and mineralocorticoids) was adjusted, which produced a favorable clinical response with progressive normalization of macrocytosis and hemoglobin levels. Long-term follow-up confirmed clinical stability and effective control of the autoimmune evolution. APS-2 is defined as the coexistence of autoimmune Addison's disease with autoimmune thyroid diseases (such as Graves' disease or Hashimoto's thyroiditis) and/or type 1 diabetes mellitus, in the absence of hypoparathyroidism. Various genetic and environmental factors appear to contribute to its development, although its exact etiology remains unknown. This clinical case supports the recommendation of active screening for autoimmune disorders in patients with Addison's disease.","PeriodicalId":18419,"journal":{"name":"Medicina-buenos Aires","volume":"85 4","pages":"872-875"},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144821959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0